Archives for May 21, 2012

← 2012

Article 13 appeal in the global functional food market: Leatherhead

By Kacey Culliney

Growth rates across the global functional food market have contracted but product development remains high and companies are increasingly focused on general health claims, covered under article 13 of the EU nutrition and health claims regulation (NHCR),...

FDA should reconsider capital costs of AERs: CRN

By Stephen Daniells

The Food & Drug Administration’s (FDA) position that dietary supplement adverse event reporting incurs no  capital costs or operating and maintenance costs is wrong and should be reconsidered, says the Council for Responsible Nutrition (CRN).